DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sandostatin (Octreotide) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Sandostatin (Octreotide) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (339)
Death (57)
Life Threatening Events (8)
Disability (5)

Reports by Reaction Type

Diarrhoea (121)Malaise (88)Abdominal Pain (79)Asthenia (70)Fatigue (68)Nausea (68)Vomiting (60)Injection Site Pain (58)Flushing (52)Blood Pressure Increased (48)Pain in Extremity (48)Pain (46)

Below are a few examples of reports where side effects / adverse reactions may be related to Sandostatin (Octreotide). For a complete list or a specific selection of reports, please use the links above.

Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-08-27

Patient: female

Reactions: Productive Cough, Contusion, Bone Pain, Chills, Flatulence, Hepatic Lesion, Neoplasm Progression, Constipation, Fall, Faeces Discoloured, Malaise, Road Traffic Accident, Depression, Cough, Ligament Sprain, Defaecation Urgency, Blood Pressure Systolic Increased, Pain in Extremity, Breast Neoplasm, Diarrhoea, Alopecia, Deep Vein Thrombosis

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, unk
    Indication: Carcinoid Tumour
    Start date: 2009-05-21

Sandostatin LAR
    Dosage: 30 mg every 4 weeks
    Indication: Carcinoid Tumour
    Start date: 2009-06-01



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-08-27

Patient: female

Reactions: Flushing, Fatigue, Diarrhoea, Pain in Extremity, Pain, Dizziness, Muscle Spasms

Drug(s) suspected as cause:
Sandostatin
    Dosage: unk ukn, unk
    Indication: Neuroendocrine Tumour

Sandostatin
    Dosage: every 12 hrs
    Start date: 2012-08-14

Sandostatin LAR
    Dosage: 30 mg, every 3 weeks
    Start date: 2012-07-04

Sandostatin LAR
    Dosage: 30 mg, every 4 weeks
    Indication: Neuroendocrine Tumour
    Start date: 2012-07-04



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-08-27

Patient: female

Reactions: Pneumonia, Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Tremor, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Feeling Jittery, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Dosage: unk ukn, unk
    Indication: Neuroendocrine Tumour
    Start date: 2011-07-11

Sandostatin LAR
    Dosage: 20 mg, qmo
    Indication: Neuroendocrine Tumour
    Start date: 2011-07-26



Possible Sandostatin side effects in male

Reported by a consumer/non-health professional from Canada on 2012-08-27

Patient: male

Reactions: Abdominal Pain, Productive Cough, Pruritus, Nasopharyngitis, Metastases To Liver, Pyrexia, Faecal Volume Increased, Hot Flush, Fatigue, Cough, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Gastrointestinal Neoplasm, Diarrhoea, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood

Drug(s) suspected as cause:
Sandostatin
    Dosage: 100 ug, tid
    Start date: 2010-03-01

Sandostatin
    Indication: Neuroendocrine Tumour
    End date: 2008-01-01

Sandostatin LAR
    Dosage: 30 mg, qmo
    Indication: Neuroendocrine Tumour
    Start date: 2010-03-13

Sandostatin LAR
    Dosage: 40 mg, every 4 weeks

Sandostatin LAR
    Dosage: 30 mg every 4 weeks

Other drugs received by patient: Antibiotics; Morphine



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-27

Patient: female

Reactions: Abdominal Pain, Fatigue, Diarrhoea, Arthralgia, Pain in Extremity, Insomnia

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, bid
    Indication: Acromegaly
    Start date: 2009-07-07

Sandostatin LAR
    Dosage: 20 mg, monthly
    Indication: Acromegaly
    Start date: 2009-07-24

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks

Sandostatin LAR
    Dosage: 30 mg, monthly



Possible Sandostatin side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24

Patient: male

Reactions: Intestinal Ischaemia, Blood Iron Decreased, Abdominal Pain, Thrombosis, Lymphadenopathy, Intestinal Obstruction, Gastrointestinal Stenosis, Blood Magnesium Decreased, Transferrin Saturation Decreased, Gastrointestinal Ulcer, Diarrhoea, Colonic Stenosis, Gastrointestinal Disorder, Hypoalbuminaemia, Abdominal Distension, Impaired Gastric Emptying, Small Intestinal Stenosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arixtra
    Start date: 2012-01-01

Arixtra
    Dosage: 2.5 mg, daily
    Start date: 2012-03-06
    End date: 2012-03-01

Atarax

Codeine Syrup

Esomeprazole Sodium
    Dosage: 40 mg, daily
    Start date: 2012-03-06

Imodium
    Dosage: 2 df, tid
    End date: 2012-03-01

Imodium
    Dosage: 3 df, qid
    Start date: 2012-03-06

Quetiapine
    Dosage: 600 mg, 1h before the dinner
    Start date: 2012-02-06

Quetiapine
    Dosage: 600 mg, in the evening
    Start date: 2012-03-06

Sandostatin
    Start date: 2012-02-01
    End date: 2012-03-01

Sandostatin
    Dosage: 100 mcg , bid
    Start date: 2012-03-06
    End date: 2012-03-01

Tranxene
    Dosage: 5 mg, in the evening
    Start date: 2012-03-06

Tranxene
    Dosage: 50 mg, tid
    Start date: 2012-01-01
    End date: 2012-03-01

Other drugs received by patient: Spasfon; Chlorpromazine HCL; Acetaminophen; Haloperidol Lactate; Augmentin '500'



Possible Sandostatin side effects in male

Reported by a physician from France on 2012-08-24

Patient: male

Reactions: Intestinal Ischaemia, Thrombosis, Abdominal Pain, Lymphadenopathy, Intestinal Obstruction, Intestinal Stenosis, Mucosal Inflammation, Incorrect Drug Administration Duration, Abdominal Distension, Small Intestinal Stenosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arixtra
    Dosage: 2.5mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01
    End date: 2012-03-01

Atarax
    Dosage: 50mg per day
    Indication: Product Used FOR Unknown Indication

Codeine Syrup
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-03-01

Imodium
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-03-01

Nexium
    Dosage: 40mg per day
    Indication: Product Used FOR Unknown Indication

Quetiapine
    Dosage: 2unit at night
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-02-06
    End date: 2012-03-01

Sandostatin
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-03-01

Tranxene
    Indication: Delirium
    Start date: 2012-01-01
    End date: 2012-03-01

Other drugs received by patient: Acetaminophen; Flagyl; Acetaminophen; Augmentin '500'; Chlorpromazine HCL; Clozapine; Rocephin; Spasfon; Haloperidol Lactate



Possible Sandostatin side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23

Patient: male

Reactions: Intestinal Ischaemia, Abdominal Pain, Abdominal Distension, Intestinal Obstruction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-02

Acetaminophen
    Indication: Product Used FOR Unknown Indication

Arixtra
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-06
    End date: 2012-03-01

Arixtra
    Start date: 2012-01-27
    End date: 2012-03-01

Atarax
    Dosage: evening
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-06

Chlorpromazine HCL
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-27

Codeine
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-03-01

Flagyl
    Indication: Product Used FOR Unknown Indication

Imodium
    Start date: 2012-02-02

Imodium
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-06
    End date: 2012-03-01

Nexium
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-06

Quetiapine Fumarate
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-02-06

Quetiapine Fumarate
    Administration route: Oral
    Start date: 2012-03-06

Rocephin
    Indication: Product Used FOR Unknown Indication

Sandostatin
    Dosage: 1 in the morning and 1 in the evening
    Start date: 2012-03-01
    End date: 2012-03-01

Sandostatin
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-03-01

Spasfon
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-02

Tranxene
    Dosage: in the evening
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-06

Tranxene
    Start date: 2012-01-27
    End date: 2012-03-01



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-08-23

Patient: female, weighing 49.4 kg (108.8 pounds)

Reactions: Weight Decreased, Rectal Haemorrhage, Pain, Oral Discomfort, Injection Site Erythema, Lymph Node Pain, Anorectal Discomfort, Abdominal Distension, Dizziness, Cough, Nervousness, Injection Site Mass, Back Pain, Nausea, Haemorrhoids, Injection Site Pain, Hypoaesthesia, Diarrhoea, Alopecia, Pollakiuria, Blood Pressure Decreased, Depressed Mood, Frustration, DRY Eye, Asthenia

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, unk
    Indication: Thyroid Cancer

Sandostatin
    Dosage: 100 ug, bid
    End date: 2012-02-23

Sandostatin LAR
    Dosage: 30 mg, qmo
    Indication: Thyroid Cancer
    Start date: 2004-07-13
    End date: 2007-03-06

Sandostatin LAR
    Dosage: 30 mg every 3 weeks
    End date: 2007-03-06



Possible Sandostatin side effects in male

Reported by a physician from Canada on 2012-08-22

Patient: male

Reactions: Abdominal Pain, Nausea, Blood Pressure Systolic Increased, Flatulence, Gastrointestinal Inflammation, Biliary Colic, Diarrhoea, Dizziness

Drug(s) suspected as cause:
Sandostatin

Sandostatin LAR
    Dosage: 20 mg, qmo
    Indication: Colitis Microscopic
    Start date: 2010-10-18

Other drugs received by patient: Budesonide; Lomotil



Possible Sandostatin side effects in male

Reported by a physician from France on 2012-08-21

Patient: male, weighing 87.0 kg (191.4 pounds)

Reactions: Intestinal Ischaemia, Dissociative Disorder, Colitis Ischaemic, Anaemia, Intestinal Obstruction, Delirium, Hypokalaemia, Lung Disorder, Hypomagnesaemia, Hypoalbuminaemia, Suicide Attempt, Septic Shock

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Arixtra
    Start date: 2012-01-01
    End date: 2012-03-01

Atarax

Clozapine
    Dosage: 300 mg to 400 mg per day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-01-12
    End date: 2012-01-19

Codeine Sulfate
    Administration route: Oral
    Start date: 2012-02-01
    End date: 2012-03-01

Imodium
    Administration route: Oral
    Indication: Diarrhoea
    Start date: 2012-02-01
    End date: 2012-03-01

Nexium
    Administration route: Oral

Sandostatin
    Start date: 2012-02-01
    End date: 2012-03-01

Seroquel
    Dosage: dose progressively increased
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-02-06
    End date: 2012-03-05

Tranxene
    Administration route: Oral
    Indication: Agitation
    Start date: 2012-01-27
    End date: 2012-03-05

Tranxene
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-01-27
    End date: 2012-03-05



Possible Sandostatin side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-20

Patient: male

Reactions: Abdominal Pain, Intestinal Ischaemia, Abdominal Distension, Intestinal Obstruction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Indication: Product Used FOR Unknown Indication

Acetaminophen
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-02

Arixtra
    Start date: 2012-03-06
    End date: 2012-03-01

Arixtra
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-27
    End date: 2012-03-01

Atarax
    Dosage: evening
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-06

Chlorpromazine HCL
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-27

Codeine
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-03-01

Flagyl
    Indication: Product Used FOR Unknown Indication

Imodium
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-06
    End date: 2012-03-01

Imodium
    Start date: 2012-02-02

Nexium
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-06

Quetiapine Fumarate
    Administration route: Oral
    Start date: 2012-02-06

Quetiapine Fumarate
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-03-06

Rocephin
    Indication: Product Used FOR Unknown Indication

Sandostatin
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-03-01

Sandostatin
    Dosage: 1 in the morning and 1 in the evening
    Start date: 2012-03-01
    End date: 2012-03-01

Spasfon
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-02

Tranxene
    Dosage: in the evening
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-06

Tranxene
    Start date: 2012-01-27
    End date: 2012-03-01



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-17

Patient: female

Reactions: Death, Abdominal Pain, Confusional State, Neoplasm Malignant, Diarrhoea

Adverse event resulted in: death

Drug(s) suspected as cause:
Sandostatin
    Start date: 2012-06-01

Sandostatin LAR
    Dosage: 30 mg, monthly
    Indication: Neuroendocrine Tumour
    Start date: 2012-06-29



Possible Sandostatin side effects in male

Reported by a physician from France on 2012-08-17

Patient: male, weighing 87.0 kg (191.4 pounds)

Reactions: Colitis Ischaemic, Intestinal Ischaemia, Dissociative Disorder, Anaemia, Intestinal Obstruction, Delirium, Hypokalaemia, Lung Disorder, Hypomagnesaemia, Hypoalbuminaemia, Suicide Attempt, Septic Shock

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Arixtra
    Start date: 2012-01-01
    End date: 2012-03-01

Atarax

Clozapine
    Dosage: 300 mg to 400 mg per day
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-01-12
    End date: 2012-01-19

Codeine Sulfate
    Administration route: Oral
    Start date: 2012-02-01
    End date: 2012-03-01

Imodium
    Administration route: Oral
    Indication: Diarrhoea
    Start date: 2012-02-01
    End date: 2012-03-01

Nexium
    Administration route: Oral

Sandostatin
    Start date: 2012-02-01
    End date: 2012-03-01

Seroquel
    Dosage: dose progressively increased
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2012-02-06
    End date: 2012-03-05

Tranxene
    Administration route: Oral
    Indication: Agitation
    Start date: 2012-01-27
    End date: 2012-03-05

Tranxene
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-01-27
    End date: 2012-03-05



Possible Sandostatin side effects in male

Reported by a consumer/non-health professional from Canada on 2012-08-16

Patient: male

Reactions: Jaundice, Abdominal Pain, Blood Bilirubin Increased, Confusional State, Agitation, Weight Decreased, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Malaise, Fatigue, Pleural Effusion, Cardiac Failure Congestive, Cough, Decreased Appetite, Lethargy, Blood Pressure Increased, Dyspnoea, Restlessness, Pain in Extremity, Ascites, Discomfort, Heart Rate Decreased, Abdominal Mass, Syncope, Micturition Disorder, Joint Swelling, Urine Colour Abnormal, Dehydration, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin

Sandostatin LAR
    Dosage: 30 mg, every 3 weeks

Sandostatin LAR
    Dosage: 20 mg, once in a month
    Indication: Neuroendocrine Tumour
    Start date: 2011-02-28

Other drugs received by patient: Sutent



Possible Sandostatin side effects in female

Reported by a physician from Canada on 2012-08-16

Patient: female

Reactions: Poor Quality Sleep, Blood Pressure Increased, Malaise, Micturition Disorder, Blood Pressure Difference of Extremities, Thermal Burn, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, unk
    Indication: Gastrinoma
    Start date: 2010-06-10

Sandostatin LAR
    Dosage: 20 mg, every 4 weeks
    Indication: Gastrinoma
    Start date: 2010-06-21

Sandostatin LAR
    Dosage: 20 mg, qmo

Sandostatin LAR
    Dosage: 20 mg, qmo



Possible Sandostatin side effects in male

Reported by a consumer/non-health professional from Canada on 2012-08-16

Patient: male

Reactions: Dyspnoea, Disorientation, Discomfort, Blood Glucose Decreased, Abdominal Discomfort, Flushing, Diarrhoea, Blood Glucose Fluctuation, Feeling Abnormal

Drug(s) suspected as cause:
Sandostatin
    Indication: Carcinoid Syndrome

Sandostatin LAR
    Dosage: 30 mg, qmo
    Indication: Carcinoid Syndrome
    Start date: 2011-10-12

Sandostatin LAR
    Dosage: 20 mg, (every 2 weeks)

Other drugs received by patient: Lantus; Novorapid



Possible Sandostatin side effects in male

Reported by a consumer/non-health professional from Germany on 2012-08-16

Patient: male

Reactions: Diabetes Mellitus, Drug Intolerance

Drug(s) suspected as cause:
Sandostatin



Possible Sandostatin side effects in male

Reported by a physician from Canada on 2012-08-14

Patient: male

Reactions: Abdominal Pain, Dyspnoea, Blood Pressure Systolic Increased, Suffocation Feeling, Wheezing, Rhinorrhoea, Injection Site Pain, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Cough, Blood Pressure Diastolic Decreased, Influenza

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Dosage: 50 ug, tid
    Indication: Carcinoid Tumour
    Start date: 2011-06-23

Sandostatin
    Dosage: 50 ug, tid
    End date: 2011-07-05

Sandostatin LAR
    Dosage: 30 mg, every 4 weeks
    Indication: Carcinoid Tumour
    Start date: 2011-07-14

Sandostatin LAR
    Dosage: 30 mg, every 4 weeks
    Start date: 2011-07-15

Other drugs received by patient: Dicyclomine; Bisoprolol; Metoprolol



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-08-13

Patient: female

Reactions: Nausea, Blood Pressure Decreased

Drug(s) suspected as cause:
Sandostatin



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-08-13

Patient: female

Reactions: Death, Fatigue, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Sandostatin
    Indication: Crohn's Disease

Sandostatin
    Dosage: 500 ug, bid
    Indication: Neoplasm Malignant
    Start date: 2012-06-28

Sandostatin LAR
    Dosage: 20 mg once a month
    Indication: Neoplasm Malignant
    Start date: 2012-06-28
    End date: 2012-06-28

Sandostatin LAR
    Indication: Crohn's Disease



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-08-10

Patient: female

Reactions: Central Nervous System Inflammation, Demyelination, Paraesthesia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-08-10

Patient: female

Reactions: Diarrhoea, Nausea, Hypotension, Headache

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Blinded NO Treatment Received
    Dosage: double blind
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-06-01
    End date: 2011-12-01

Blinded Som230
    Dosage: double blind
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-06-01
    End date: 2011-12-01

Sandostatin
    Dosage: double blind
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-06-01
    End date: 2011-12-01

Sandostatin LAR
    Dosage: 40 mg, qmo (every 4 weeks)
    Indication: Metastatic Carcinoid Tumour
    Start date: 2009-07-06
    End date: 2011-12-13



Possible Sandostatin side effects in male

Reported by a physician from Canada on 2012-08-10

Patient: male

Reactions: Haemorrhage, Hypotension, Tachycardia, Malaise, Postoperative Wound Infection, Pleural Effusion, Bone Disorder, Septic Shock, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Dosage: 150 ug, tid
    Indication: Haemorrhage

Sandostatin LAR
    Dosage: 30 mg, once a month
    Indication: Haemorrhage
    Start date: 2012-06-20



Possible Sandostatin side effects in female

Reported by a consumer/non-health professional from Canada on 2012-08-07

Patient: female

Reactions: Fatigue, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Sandostatin
    Dosage: 500 ug, bid
    Indication: Neoplasm Malignant
    Start date: 2012-06-28

Sandostatin
    Indication: Crohn's Disease

Sandostatin LAR
    Indication: Crohn's Disease

Sandostatin LAR
    Dosage: 20 mg once a month
    Indication: Neoplasm Malignant
    Start date: 2012-06-28
    End date: 2012-06-28



Possible Sandostatin side effects in male

Reported by a physician from Canada on 2012-08-07

Patient: male

Reactions: Tachycardia, Hypotension, Wound Secretion, Occult Blood Positive, Malaise, Pulmonary Oedema, Bone Disorder, Septic Shock, Asthenia, TOE Amputation, Post Procedural Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Dosage: 150 ug, tid
    Indication: Haemorrhage

Sandostatin LAR
    Dosage: 30 mg, once a month
    Indication: Haemorrhage
    Start date: 2012-06-20



Possible Sandostatin side effects in female

Reported by a physician from United States on 2012-08-07

Patient: female, weighing 69.3 kg (152.5 pounds)

Reactions: Cardio-Respiratory Arrest, Post Procedural Complication, Pneumothorax, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Everolimus (Afiitor, RAD-001)
    Dosage: 150 mg
    End date: 2012-07-12

Sandostatin
    Dosage: 20 mg
    End date: 2012-07-20



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-07

Patient: female

Reactions: Large Intestine Perforation, Drug Ineffective, Urinary Tract Infection, Iatrogenic Injury, Intestinal Obstruction, Foot Fracture, Postoperative Wound Infection, Diarrhoea, Dehydration, Blood Pressure Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Dosage: 100 ug, bid
    Indication: Crohn's Disease
    Start date: 2010-01-01

Sandostatin
    Dosage: 100 ug, bid
    Start date: 2010-02-01

Sandostatin LAR
    Dosage: 30 mg, once a month
    Indication: Crohn's Disease
    Start date: 2010-07-29
    End date: 2010-08-31

Sandostatin LAR
    Dosage: 40 mg, every 4 weeks
    Start date: 2010-10-18

Sandostatin LAR
    Dosage: 30 mg, tiw

Sandostatin LAR
    Dosage: 30 mg, tiw

Sandostatin LAR
    Dosage: 20 mg, tiw



Possible Sandostatin side effects in male

Reported by a consumer/non-health professional from Canada on 2012-08-06

Patient: male

Reactions: Blood Bilirubin Increased, Confusional State, Weight Decreased, Abdominal Pain, Agitation, Jaundice, Bile Duct Obstruction, Urinary Incontinence, Constipation, Loss of Consciousness, Fatigue, Malaise, Pleural Effusion, Cough, Decreased Appetite, Lethargy, Cardiac Failure Congestive, Blood Pressure Increased, Dyspnoea, Pain in Extremity, Restlessness, Discomfort, Ascites, Syncope, Abdominal Mass, Heart Rate Decreased, Joint Swelling, Micturition Disorder, Urine Colour Abnormal, Dehydration, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin

Sandostatin LAR
    Dosage: 20 mg, once in a month
    Indication: Neuroendocrine Tumour
    Start date: 2011-02-28

Sandostatin LAR
    Dosage: 30 mg, every 3 weeks

Other drugs received by patient: Sutent



Possible Sandostatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-06

Patient: female

Reactions: Nausea, Diarrhoea, Hypotension, Headache

Drug(s) suspected as cause:
Blinded NO Treatment Received
    Dosage: double blind
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-06-01
    End date: 2011-12-01

Blinded Som230
    Dosage: double blind
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-06-01
    End date: 2011-12-01

Sandostatin
    Dosage: double blind
    Indication: Metastatic Carcinoid Tumour
    Start date: 2011-06-01
    End date: 2011-12-01

Sandostatin LAR
    Dosage: 40 mg, qmo (every 4 weeks)
    Indication: Metastatic Carcinoid Tumour
    Start date: 2009-07-06
    End date: 2011-12-13

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014